Business
Bio Spectrum
Aster DM Healthcare to inject Rs 580 Cr to build 5th hospital in Bengaluru
Aster DM Healthcare, one of India's leading integrated healthcare providers, in a move to strengthen its footprint in one of India's fastest-growing healthcare hubs, Bengaluru, has announced Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min |
September 2025
Bio Spectrum
MedGenome raises $47.5M to expand access to genomics offerings in India
Bengaluru-based genomic diagnostics and research services company MedGenome has raised $47.5 million in its Series E funding round, co-led by Maj Invest, a private equity firm, joining as a new investor, along with existing investor Novo Holdings.
1 min |
September 2025
Bio Spectrum
ICT and ITRI sign agreement to catalyse Rs 30 Cr support for Mumbai Biocluster Building
The Institute of Chemical Technology (ICT), Mumbai and the India's Translational Research Initiative (ITRI) have signed a formal Expression of Interest (EoI) to jointly catalyse the construction of the Mumbai Biocluster - a cutting-edge, eight-storey facility dedicated to advancing translational biopharmaceutical research, training, and manufacturing in India, with an investment of Rs 30 crore.
1 min |
September 2025
Bio Spectrum
IIT Indore & Mehta Family Foundation to launch academic schools in Sustainability and Biomedical Engineering
The Indian Institute of Technology (IIT) Indore, with support of the Bhupat & Jyoti Mehta Family Foundation (MFF), has announced a landmark partnership to establish two new academic schools at the IIT Indore campus: Mehta Family School of Sustainability and Mehta Family School of Biosciences and Biomedical Engineering.
1 min |
September 2025
Bio Spectrum
NIT Calicut develops nano-sensor to detect deadly infections in minutes
A team of scientists at the National Institute of Technology (NIT), Calicut has developed a new highly sensitive, lowcost, point-of-care device with an electrochemical biosensor that could help early diagnosis of sepsis at the bedside of the patient.
1 min |
September 2025
Bio Spectrum
Yann D'Herve joins Cohance Lifesciences as CEO of CDMO Business
Hyderabad-based Cohance Lifesciences (formerly Suven Pharmaceuticals Limited), a leading integrated Contract Development and Manufacturing Organisation (CDMO), has announced the appointment of Yann D'Herve as Chief Executive Officer (CEO) of the company's CDMO business.
1 min |
September 2025
Bio Spectrum
Lilly expands India presence with new Hyderabad site to accelerate global digital innovation
Eli Lilly and Company (India) has announced the opening of its new technology and innovation site in Hyderabad; a new strategic hub for advanced digital and technology capabilities that will improve efficiency across Lilly's global operations.
1 min |
September 2025
Bio Spectrum
Agilent opens Experience Centre in Hyderabad to support India's global biopharma ambitions
Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its new Biopharma Experience Centre in Hyderabad.
1 min |
September 2025
Bio Spectrum
Thermo Fisher announces launch of Scios 3 & Talos 12 Electron Microscopes
Thermo Fisher Scientific has announced the launch of two new electron microscopes, each significantly contributing to the democratisation of research in the sciences.
1 min |
September 2025
Bio Spectrum
Eppendorf unveils next-generation pipettes in India for better accuracy and precision
Eppendorf has announced the worldwide sales start of its next generation of mechanical pipettes, the Eppendorf Research 3 neo.
1 min |
September 2025
Bio Spectrum
Healthium Medtech names Rajnish Damani as Group COO
Bengaluru-based Healthium Medtech, a global player in medical devices, focused on products in the surgical and post-surgical ecosystem including wound closure, advanced wound care, arthroscopy and infection prevention segments, has announced the appointment of Rajnish Damani as Group Chief Operating Officer (COO).
1 min |
September 2025
Bio Spectrum
Intas Pharma unveils India's first novel immunotherapy for advanced small cell lung cancer
Ahmedabad-based Intas Pharmaceuticals has launched Hetronifly (Serplulimab), the first PD-1 inhibitor globally approved for the treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC), in the Indian market.
1 min |
September 2025
Bio Spectrum
Chander Shekhar Sibal steps in as India CEO of SS Innovations International
Gurugram-based medtech startup SS Innovations International has announced the appointment of Chander Shekhar Sibal as the Chief Executive Officer of India business.
1 min |
September 2025
Bio Spectrum
Dr Surender Kumar Dabas joins Manipal Hospitals
Manipal Hospital, a leading healthcare institution in Delhi NCR with hospitals across Delhi, Gurugram, and Ghaziabad, has announced the appointment of India's most renowned and celebrated robotic onco-surgeons, Dr Surender Kumar Dabas as Chairman - Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
1 min |
September 2025
Bio Spectrum
Indo-US scientists decode hair loss at molecular level, paving way for regrowth without transplants
Scientists have mapped the complete molecular network that controls human hair growth, offering what may be the clearest path yet to restoring hair without surgery, drugs, or transplantation.
1 min |
September 2025
Bio Spectrum
Maxivision Super Speciality Eye Hospitals invests Rs 100 Cr to expand network across Chennai
Maxivision Super Speciality Eye Hospitals, one of India's fastestgrowing eye care providers, has announced its strategic expansion in Chennai with the launch of 10 eye hospitals/vision centres across Chennai.
1 min |
September 2025
Bio Spectrum
International medical programme for Indian students to practice in the US and Canada
With a growing number of Indian students aspiring to pursue medical education and careers in the United States, Canada, and beyond, Xavier University School of Medicine, Aruba (XUSOM), in collaboration with KLE University, India, has launched a unique international medical pathway to support this ambition.
1 min |
September 2025
Bio Spectrum
Deepak Bagla assumes charge as Mission Director of Atal Innovation Mission
NITI Aayog has announced that Deepak Bagla has officially assumed charge as the Mission Director of the Atal Innovation Mission (AIM).
1 min |
September 2025
Bio Spectrum
Ministry of Ayush signs 2 MoUs to strengthen conservation of medicinal plants
Two significant Memoranda of Understanding (MoUs) have been signed by the National Medicinal Plants Board (NMPB), Ministry of Ayush, Government of India.
1 min |
September 2025
Bio Spectrum
Fujifilm India unveils ENDOVEDA to revolutionise clinical reporting in gastroenterology
Fujifilm India, a global leader in healthcare technology, recently unveiled its latest innovation in endoscopy reporting, ENDOVEDA, at the Endocon 2025 conference in Jaipur.
1 min |
September 2025
Bio Spectrum
Medistep Healthcare eyes Rs 16.09 Cr fundraise to acquire new plant & machinery
Medistep Healthcare is set to raise approximately Rs 16.09 crore through its upcoming fixed-price Initial Public Offering (IPO), with the primary objective of strengthening its manufacturing infrastructure through the acquisition of advanced plant and machinery.
1 min |
September 2025
Bio Spectrum
Revvity introduces innovative reagent technology to accelerate therapeutics development
US-based Revvity, Inc. has announced the launch of pHSense reagents, a powerful technology designed to advance internalisation studies in drug discovery.
1 min |
September 2025
Bio Spectrum
Punjab launches Cancer Care Pathways
The Government of Punjab has launched the Punjab Cancer Care Pathways, a comprehensive initiative introducing Standard Treatment Guidelines (STGs) and streamlined care models for breast, cervical, oral, lung, and liver cancers.
1 min |
September 2025
Bio Spectrum
How Digital Twins Transform Drug Development Processes
Digital twins enable a move from a slow, trial-anderror approach to a highly predictive, efficient, and data-driven drug discovery process-getting safer, more effective treatments to patients faster than ever before.
5 min |
September 2025
Bio Spectrum
WHO certifies Suriname malaria-free
Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO).
1 min |
August 2025
Bio Spectrum
Torrent Pharma buys controlling stake in JB Pharma from KKR for Rs 25,689 Cr valuation
Ahmedabad-based Torrent Pharmaceuticals and global investment firm KKR have announced that Torrent has entered into definitive agreements to acquire controlling stake in Mumbai-based J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR at an Equity Valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities.
1 min |
August 2025
Bio Spectrum
Suraksha Diagnostics injects Rs 22 Cr to establish Eastern India's largest genomics lab
Suraksha Diagnostics, one of the leading diagnostics chains in Eastern India, has launched one of the largest and a state-of-theart genomics lab in Eastern India.
1 min |
August 2025
Bio Spectrum
Illumina buys SomaLogic for $425 M to accelerate proteomics business
Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.
1 min |
August 2025
Bio Spectrum
Kashmik Formulation to expand capacity, eyes Rs 100 Cr revenue in FY26
Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in international markets, and enhancing operational efficiencies through automation.
1 min |
August 2025
Bio Spectrum
WHO highlights risks associated with use of semaglutide medicines
The World Health Organisation (WHO) is alerting healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicinesOzempic, Rybelsus, and Wegovy.
1 min |